The loss or downregulation of CBX7 gene expression was associated with several cancer, including PACA, thyroid cancer (THCA), CRC, NSCLC, bladder carcinoma (BLCA), and HCC [54–59]. Here, CBX7 is linked to hepatocellular carcinoma.